FROM PUBLIC EVENTS · 2026-11-15

Current stage

  1. Discovery · preclinical
  2. Early clinical · first deals
  3. Late clinical · capacity
  4. Commercial · sales
  1. Global approvals · expansion
  2. M&A · integration
  3. Pipeline reshaping

Late clinical · capacity Expanding injectable production with a new Pyeongtaek plant alongside sales of its general anaesthetic.

  • Report on the new Pyeongtaek plant investment and its funding. Source

Roles often seen at this stageManufacturing & MSAT · Quality QA & QC · Sales & marketing

Companies at the same stage and their people flow →

← Company library
Korea / Company briefSources checked 2026-11-15

Hana Pharm

A pharmaceutical company producing and selling injectables centred on anaesthetics and cardiovascular drugs, including the general anaesthetic Byfavo.

Byfavo (remimazolam)

Marketed

A general anaesthetic approved and launched in Korea, made at the company's Hagil plant.

Progress reported

Is investing in a new Pyeongtaek plant to expand injectable production.

Official role guide

Hana Pharm careers

Current availability unconfirmed

Observed 2026-11-15

Work
Unconfirmed — The official careers page could not be confirmed.
Experience & requirements
Unconfirmed — The official careers page could not be confirmed.

Information from a role guide does not establish a current vacancy.

Sources & coverage 2

A brief based on selected official material, not an exhaustive product or vacancy list.

  1. 하나제약, 생산시설 확충…'순환기·마취제' 입지 다진다 ↗핀포인트뉴스 · Published Date unconfirmed · Sources checked 2026-11-15 · Original unavailable
  2. 하나제약, 마취제 신약 '바이파보주' 출시 ↗약업신문 · Published Date unconfirmed · Sources checked 2026-11-15 · Original unavailable